Wen-Kai Shi
- Molecular Biology
- Cancer Research top 10%
- Hepatology top 5%
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Hui‐Chuan SunXiao‐Dong ZhuZhao–You TangDongmei GaoChenghao WangYuanyuan ZhangKangshuai LiShi-Zhe Zhang
- Topics
- CAR-T cell therapy research (2 papers)Ubiquitin and proteasome pathways (2 papers)Immune Cell Function and Interaction (2 papers)
- Cited by
- HepatologyCancer ResearchOncology
In The Last Decade
Wen-Kai Shi
7 papers receiving 433 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Molecular Biology 212
- Cancer Research 185
- Hepatology 148
- Oncology 102
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Wen-Kai Shi
This map shows the geographic impact of Wen-Kai Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Kai Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Kai Shi more than expected).
Fields of papers citing papers by Wen-Kai Shi
This network shows the impact of papers produced by Wen-Kai Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Kai Shi. The network helps show where Wen-Kai Shi may publish in the future.
Co-authorship network of co-authors of Wen-Kai Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Kai Shi. A scholar is included among the top collaborators of Wen-Kai Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Kai Shi. Wen-Kai Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 22 | |
| 5 | Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinationsbreakdown → | 159 |
| 6 | 45 | |
| 7 | 177 | |
| 8 | Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. | 29 |
About Wen-Kai Shi
Wen-Kai Shi is a scholar working on Cancer Research, Hepatology and Cell Biology, having authored 8 papers that have together received 435 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hepatology (148 citations), Cancer Research (185 citations) and Oncology (102 citations). Wen-Kai Shi has collaborated with scholars based in China and Ethiopia. Frequent co-authors include Hui‐Chuan Sun, Xiao‐Dong Zhu, Zhao–You Tang, Dongmei Gao, Chenghao Wang, Yuanyuan Zhang, Kangshuai Li, Shi-Zhe Zhang, Hao Cai and Chengdong Qin. Their work appears in journals such as Gene, Cell Death and Disease and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.